Memantine Augmentation in Obsessive-Compulsive Disorder: A Systematic Review and Meta-analysis
CNS Drugs · 2026-09 · 40 (9) · 1243-1257
DOI: 10.1007/s40263-026-01318-4 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift CNS Drugs, online erschienen am 22.07.2026. Verfasst von Stanley Lyndon und 1 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Medical School, Boston, MA, USA. slyndon@bwh.harvard.edu. Hauptthemen laut MEDLINE: Memantine, Obsessive-Compulsive Disorder. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Harvard Medical School, Boston, MA, USA. slyndon@bwh.harvard.edu.
- Center for Brain/Mind Medicine, Mass General Brigham, 60 Fenwood Rd, Boston, MA, 02115, USA. slyndon@bwh.harvard.edu.
- Division of Neuropsychiatry, Mass General Brigham, Boston, MA, USA. slyndon@bwh.harvard.edu.
- Department of Psychiatry, Frank H. Netter MD School of Medicine, North Haven, CT, USA.
Zitieren
APA
Lyndon, S., & McNally, D. R. (2026). Memantine Augmentation in Obsessive-Compulsive Disorder: A Systematic Review and Meta-analysis. CNS Drugs, 40(9), 1243-1257. https://doi.org/10.1007/s40263-026-01318-4
Vancouver
Lyndon S, McNally DR. Memantine Augmentation in Obsessive-Compulsive Disorder: A Systematic Review and Meta-analysis. CNS Drugs. 2026;40(9):1243-1257. doi:10.1007/s40263-026-01318-4
BibTeX
@article{Lyndon2026,
author = {Lyndon, Stanley and McNally, Donald R},
title = {Memantine Augmentation in Obsessive-Compulsive Disorder: A Systematic Review and Meta-analysis},
journal = {CNS Drugs},
year = {2026},
volume = {40},
number = {9},
pages = {1243--1257},
doi = {10.1007/s40263-026-01318-4}
}
EUVIMED